| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.01 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.01 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.01 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.14 | 0.01 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | -0.11 | 0.01 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.02 |